Kloramfenikol Takeda

Chloramphenicol, the active ingredient in Kloramfenikol Takeda, is an amphenicol presented as an ophthalmic solution for ocular use. It is employed to treat bacterial infections of the eye, particularly conjunctivitis, in patients requiring topical antibiotic therapy.

GNH USA supplies Kloramfenikol Takeda as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Chloramphenicol ophthalmic solution is used to manage bacterial infections of the ocular surface and related tissues. - Bacterial conjunctivitis: reduces bacterial load and accelerates symptom resolution. - Keratitis (bacterial): helps eradicate pathogenic bacteria and prevent corneal scarring. - Post‑operative ocular infection: provides prophylactic coverage against bacterial contamination after eye surgery.

Adverse reactions may occur with topical ocular use of chloramphenicol.

Common Side Effects: - Local irritation: mild burning or stinging upon instillation. - Redness: transient conjunctival hyperemia. - Pruritus: itching of the ocular surface. - Lacrimation: increased tearing. - Foreign body sensation: feeling of grit in the eye.

Serious or Rare Side Effects: - Allergic contact dermatitis: swelling, erythema, or rash around the eye. - Stevens‑Johnson syndrome: severe mucocutaneous reaction requiring immediate medical attention. - Bone marrow suppression: rare systemic effect manifesting as anemia or leukopenia. - Vision loss: extremely rare, may indicate severe ocular toxicity. - Corneal ulceration: persistent ulcer despite therapy.

When prescribing chloramphenicol ophthalmic solution, consider the following safety measures. - Allergy assessment: avoid use in patients with known hypersensitivity to chloramphenicol or other amphenicols. - Pregnancy and lactation: use only if the potential benefit outweighs risk, as safety data are limited. - Duration of therapy: limit to the shortest effective period to reduce resistance development. - Contact lens wearers: advise removal of lenses before and after instillation to prevent drug absorption. - Monitoring: observe for signs of systemic toxicity if large ocular surface area is treated. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight, and retain in original container.

Chloramphenicol ophthalmic solution may interact with other ocular or systemic agents.

Major Interactions (Avoid): - Systemic aminoglycosides: concurrent use may increase risk of ototoxicity. - Systemic anticoagulants: potential for enhanced bleeding if systemic absorption occurs.

Moderate Interactions (Monitor Closely): - Other topical antibiotics: may reduce efficacy or increase resistance. - Non‑steroidal anti‑inflammatory eye drops: monitor for additive irritation. - Corticosteroid eye drops: assess for delayed healing of infections. - Systemic cytochrome P450 inhibitors: may affect chloramphenicol metabolism if absorbed.